Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS Genet ; 20(1): e1011111, 2024 Jan.
Article in English | MEDLINE | ID: mdl-38206959

ABSTRACT

Meiosis is a highly conserved feature of sexual reproduction that ensures germ cells have the correct number of chromosomes prior to fertilization. A subset of microtubules, known as the spindle, are essential for accurate chromosome segregation during meiosis. Building evidence in mammalian systems has recently highlighted the unexpected requirement of the actin cytoskeleton in chromosome segregation; a network of spindle actin filaments appear to regulate many aspects of this process. Here we show that Drosophila oocytes also have a spindle population of actin that appears to regulate the formation of the microtubule spindle and chromosomal movements throughout meiosis. We demonstrate that genetic and pharmacological disruption of the actin cytoskeleton has a significant impact on spindle morphology, dynamics, and chromosome alignment and segregation during maturation and the metaphase-anaphase transition. We further reveal a role for calcium in maintaining the microtubule spindle and spindle actin. Together, our data highlights potential conservation of morphology and mechanism of the spindle actin during meiosis.


Subject(s)
Actins , Drosophila , Animals , Spindle Apparatus/physiology , Meiosis , Microtubules , Oocytes , Actin Cytoskeleton , Chromosome Segregation , Mammals
2.
Neurochem Int ; 139: 104815, 2020 10.
Article in English | MEDLINE | ID: mdl-32758587

ABSTRACT

Parkinson's disease (PD) is a common neurodegenerative disease. Damage to energy metabolism and reduced adenosine triphosphate (ATP) levels in dopaminergic neurons are common features of PD. Previous studies suggested that the occurrence of PD often affects glucose metabolism and ATP production in the brain, and increased glycolysis or ATP production protects dopaminergic neuronal degeneration in the brain of PD patients. These systems may provide new potential therapeutic targets for the prevention of PD. The present study investigated the inhibitory action of polydatin (PLD) on early dopaminergic neuronal degeneration induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). The results showed that PLD protected against MPTP-induced early dopaminergic neuronal degeneration. PLD reduced the MPTP-induced loss of dopaminergic neurons in substantia nigra and striatum, inhibited the occurrence of neural apoptosis, and restored motor function in mice. PLD also increased the continuous activity duration and rhythm amplitude in mice during the circadian activity test. PLD improved glucose metabolism in the brain and restored ATP production levels. These observations suggest that PLD attenuates MPTP-induced early PD-like symptoms, and its mechanism of action may be associated with the promotion of glucose metabolism in neurons.


Subject(s)
Dopaminergic Neurons/metabolism , Drugs, Chinese Herbal/therapeutic use , Glucosides/therapeutic use , Glycolysis/physiology , Parkinsonian Disorders/drug therapy , Parkinsonian Disorders/metabolism , Stilbenes/therapeutic use , Animals , Dopaminergic Neurons/drug effects , Dopaminergic Neurons/pathology , Dose-Response Relationship, Drug , Drugs, Chinese Herbal/pharmacology , Glucosides/pharmacology , Glycolysis/drug effects , Male , Mice , Mice, Inbred BALB C , Parkinsonian Disorders/pathology , Stilbenes/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...